{
    "clinical_study": {
        "@rank": "42070", 
        "brief_summary": {
            "textblock": "To assess the relative efficacy of oral versus intravenous hydration during foscarnet sodium\n      (Foscavir) induction therapy, as determined by changes in creatinine clearance. To estimate\n      the timing and volume of oral fluid hydration required to establish a diuresis before and\n      during intravenous Foscavir therapy. To assess the general tolerance of two hydration\n      regimens by the adverse event profile associated with each."
        }, 
        "brief_title": "A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)", 
        "condition": [
            "Cytomegalovirus Retinitis", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Retinitis", 
                "Cytomegalovirus Retinitis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients are randomized to receive oral hydration versus intravenous hydration therapy\n      during concomitant intermittent intravenous Foscavir therapy for treatment of\n      cytomegalovirus (CMV) retinitis. Treatment continues during 2 or 3 weeks of induction\n      Foscavir therapy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  Documented HIV infection.\n\n          -  Recent diagnosis of CMV retinitis, by ophthalmoscopic appearance, that requires\n             induction therapy.\n\n          -  No corneal, lens, or vitreous opacification that precludes examination of the fundi.\n\n          -  No evidence of other end organ CMV infection.\n\n          -  No evidence of tuberculous, diabetic, or hypertensive retinopathy.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Clinically significant cardiac, pulmonary, neurologic, gastrointestinal or renal\n             impairment that would prevent adequate voluntary oral hydration (e.g., intubation,\n             coma, status post-gastrectomy, colon resection, gastrointestinal tumors,\n             malabsorption, chronic diarrhea) OR with which hydration would be hazardous (e.g.,\n             congestive heart failure).\n\n          -  Known allergy to foscarnet or related compounds.\n\n          -  Considered noncompliant or unreliable for study participation.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Any investigational drug.\n\n          -  Potentially nephrotoxic drugs (e.g., amphotericin B, aminoglycosides, cisplatin).\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Any investigational drug within 28 days prior to study entry.\n\n          -  Potentially nephrotoxic drugs (e.g., amphotericin B, aminoglycosides, cisplatin)\n             within 7 days prior to study entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "112", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002125", 
            "org_study_id": "020H", 
            "secondary_id": "93-FOS-31"
        }, 
        "intervention": {
            "intervention_name": "Foscarnet sodium", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Foscarnet", 
                "Phosphonoacetic Acid"
            ]
        }, 
        "keyword": [
            "Retinitis", 
            "Infusions, Intravenous", 
            "Foscarnet", 
            "Cytomegalovirus Infections", 
            "Administration, Oral", 
            "Acquired Immunodeficiency Syndrome", 
            "Fluid Therapy"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beverly Hills", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90210"
                    }, 
                    "name": "Dr Ralph Hansen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90067"
                    }, 
                    "name": "Dr G Michael Wool"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "900246970"
                    }, 
                    "name": "Dr Milan Fiala"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Redwood City", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94063"
                    }, 
                    "name": "AIDS Community Research Consortium"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30309"
                    }, 
                    "name": "Ingenix Kern McNeill Decatur"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46204"
                    }, 
                    "name": "Dr John Karedes"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berkley", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48072"
                    }, 
                    "name": "Dr Paul Benson"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Somerville", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08876"
                    }, 
                    "name": "Dr Ronald Nahass"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "Dr Ronald J Grossman"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14620"
                    }, 
                    "name": "Community Health Network"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78705"
                    }, 
                    "name": "Austin Infectious Disease Consultants"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)", 
        "overall_official": {
            "last_name": "Wool GM", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002125"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Astra USA", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 1997"
    }, 
    "geocoordinates": {
        "AIDS Community Research Consortium": "37.485 -122.236", 
        "Austin Infectious Disease Consultants": "30.267 -97.743", 
        "Community Health Network": "43.161 -77.611", 
        "Dr G Michael Wool": "34.052 -118.244", 
        "Dr John Karedes": "39.769 -86.158", 
        "Dr Milan Fiala": "34.052 -118.244", 
        "Dr Paul Benson": "42.503 -83.184", 
        "Dr Ralph Hansen": "34.074 -118.4", 
        "Dr Ronald J Grossman": "40.714 -74.006", 
        "Dr Ronald Nahass": "40.574 -74.61", 
        "Ingenix Kern McNeill Decatur": "33.749 -84.388"
    }
}